Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Traws Pharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 19 | 19 | 0 |
| Shares | 1.17M | 1.73M | +561.9K (+48.0%) |
| Value | $10.2M | $3.98M | −$6.26M (−61.1%) |
New holders (3)
Institutions that held Traws Pharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 330,000 | $759.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,261 | $7.50K | 0.00% |
| FMR LLC | 2 | $5 | 0.00% |
Sold out (3)
Institutions that held Traws Pharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Renaissance Technologies LLC | 10,052 | $89.3K |
| Group One Trading, L.P. | 1,164 | $10.3K |
| Pacific Capital Wealth Advisors, Inc | 2 | $18 |